// App-Quantinova.ai

PB0935 : Plasma MiRNAs and the Risk of Venous Thromboembolism in Patients with Glioblastoma: A Nested Case-control Study

Researchers

Presenter

  • J. Riedl

Principal Investigators

  • M. Hackl

  • M. Preusser

  • I. Pabinger

  • C. Ay

Medical Centers

  • Medical University of Vienna, Vienna, Austria

  • TAmiRNA GmbH, Vienna, Austria, Vienna, Austria

  • Medical University of Vienna, Department of Medicine I, Division of Oncology, Vienna, Wien, Austria

  • Medical University of Vienna, Department of Neurosurgery, Vienna, Wien, Austria

  • Dept. of Medicine I, Div. of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria

Locations

  • Austria

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Oncology (ONC)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

  • Glioblastoma

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved